Genertec Universal Medical Group Company Limited (2666.HK)
- Previous Close
4.700 - Open
4.670 - Bid 4.710 x --
- Ask 4.740 x --
- Day's Range
4.650 - 4.750 - 52 Week Range
3.570 - 5.400 - Volume
7,402,500 - Avg. Volume
3,820,341 - Market Cap (intraday)
8.909B - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
4.40 - EPS (TTM)
1.070 - Earnings Date Mar 27, 2024
- Forward Dividend & Yield 0.34 (7.22%)
- Ex-Dividend Date Jun 9, 2023
- 1y Target Est
7.21
Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance Business and Hospital Group Business. The Finance Business segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group Business segment engages in the provision of medical services; hospital and healthcare management; and import, export, and domestic trading of medical-related goods. The company is also involved in the provision of medical technology; construction and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.
www.umcare.cn21,089
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 2666.HK
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2666.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2666.HK
Valuation Measures
Market Cap
8.89B
Enterprise Value
61.44B
Trailing P/E
4.39
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.66
Price/Book (mrq)
0.47
Enterprise Value/Revenue
4.50
Enterprise Value/EBITDA
18.00
Financial Highlights
Profitability and Income Statement
Profit Margin
15.67%
Return on Assets (ttm)
2.80%
Return on Equity (ttm)
10.98%
Revenue (ttm)
13.46B
Net Income Avi to Common (ttm)
2.02B
Diluted EPS (ttm)
1.070
Balance Sheet and Cash Flow
Total Cash (mrq)
3.16B
Total Debt/Equity (mrq)
234.07%
Levered Free Cash Flow (ttm)
--
Research Analysis: 2666.HK
Company Insights: 2666.HK
2666.HK does not have Company Insights